BioNTech's Q2 revenue down by 39.79% to €3.2B

Monday, 08. August 2022 12:02

BioNTech SE announced on Monday that its revenue in the second quarter of the year saw an annual decline of 39.79% to reach €3.196 billion. The company's net profit decreased by 40.01% in comparison with the same trimester in 2021 to land at €1.672 billion, while its operating income went down by 47.35% over the same period to €2.210 billion. Its diluted earnings per share (EPS) fell by 40.11% year-on-year to €6.45 per share.

"With our initiatives around variant-adapted COVID-19 vaccine candidates, we expect an uptake in demand in our key markets in the fourth quarter of 2022, subject to regulatory approval," BioNTech Chief Financial Officer (CFO) Jens Holstein commented on the results.

Following the release of the report, BioNTech's shares plunged by 4.32% in premarket trading.

Related Links: BioNTech SE
Author:
Baha Breaking News (BBN) / JR